Literature DB >> 10465554

Binding of Zn(II), Cu(II), and Fe(II) ions to Alzheimer's A beta peptide studied by fluorescence.

W Garzon-Rodriguez1, A K Yatsimirsky, C G Glabe.   

Abstract

Binding of Zn(II), Cu(II) and Fe(II) ions to A beta1-40, A beta1-42 and a single tryptophan mutant of Abeta 1-40 in solution at pH 7.4 was studied by fluorescent titration. Job plots and fitting of titration curves revealed formation of 1:1 and 1:2 peptide-metal complexes. For dimeric peptides A beta1-40 and A betaF4W the order of metal to peptide affinities is Fe < Cu > Zn, which is in agreement with the Irving-Williams series of complex stability. The affinity of A beta1-42 for Fe increases dramatically upon aggregation: K(D) changes from ca. 100 to ca. 0.2 microM.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10465554     DOI: 10.1016/s0960-894x(99)00357-1

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  23 in total

1.  Calorimetric investigation of copper(II) binding to Aβ peptides: thermodynamics of coordination plasticity.

Authors:  Cristina Sacco; Rachel A Skowronsky; Sunitha Gade; John M Kenney; Anne M Spuches
Journal:  J Biol Inorg Chem       Date:  2012-01-22       Impact factor: 3.358

2.  Structural and thermodynamical properties of CuII amyloid-beta16/28 complexes associated with Alzheimer's disease.

Authors:  Luc Guilloreau; Luminita Damian; Yannick Coppel; Honoré Mazarguil; Mathias Winterhalter; Peter Faller
Journal:  J Biol Inorg Chem       Date:  2006-08-22       Impact factor: 3.358

3.  Inhibition of Aβ42 peptide aggregation by a binuclear ruthenium(II)-platinum(II) complex: Potential for multi-metal organometallics as anti-amyloid agents.

Authors:  Amit Kumar; Lamaryet Moody; Jason F Olaivar; Nerissa A Lewis; Rahul L Khade; Alvin A Holder; Yong Zhang; Vijayaraghavan Rangachari
Journal:  ACS Chem Neurosci       Date:  2010-08-23       Impact factor: 4.418

4.  Engineering adherent bacteria by creating a single synthetic curli operon.

Authors:  Benoît Drogue; Philippe Thomas; Laurent Balvay; Claire Prigent-Combaret; Corinne Dorel
Journal:  J Vis Exp       Date:  2012-11-16       Impact factor: 1.355

5.  Structural characterization of copper(II) binding to alpha-synuclein: Insights into the bioinorganic chemistry of Parkinson's disease.

Authors:  Rodolfo M Rasia; Carlos W Bertoncini; Derek Marsh; Wolfgang Hoyer; Dmitry Cherny; Markus Zweckstetter; Christian Griesinger; Thomas M Jovin; Claudio O Fernández
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-14       Impact factor: 11.205

6.  Distinct effects of Zn2+, Cu2+, Fe3+, and Al3+ on amyloid-beta stability, oligomerization, and aggregation: amyloid-beta destabilization promotes annular protofibril formation.

Authors:  Wei-Ting Chen; Yi-Hung Liao; Hui-Ming Yu; Irene H Cheng; Yun-Ru Chen
Journal:  J Biol Chem       Date:  2011-01-07       Impact factor: 5.157

7.  Ternary complexes of iron, amyloid-beta, and nitrilotriacetic acid: binding affinities, redox properties, and relevance to iron-induced oxidative stress in Alzheimer's disease.

Authors:  Dianlu Jiang; Xiangjun Li; Renee Williams; Sveti Patel; Lijie Men; Yinsheng Wang; Feimeng Zhou
Journal:  Biochemistry       Date:  2009-08-25       Impact factor: 3.162

Review 8.  Copper in the brain and Alzheimer's disease.

Authors:  Ya Hui Hung; Ashley I Bush; Robert Alan Cherny
Journal:  J Biol Inorg Chem       Date:  2009-10-28       Impact factor: 3.358

Review 9.  Physiological roles of amyloid-beta and implications for its removal in Alzheimer's disease.

Authors:  Glenda M Bishop; Stephen R Robinson
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

10.  Cu(II)-Zn(II) Cross-Modulation in Amyloid-Beta Peptide Binding: An X-ray Absorption Spectroscopy Study.

Authors:  Emiliano De Santis; Velia Minicozzi; Olivier Proux; Giancarlo Rossi; K Ishara Silva; Matthew J Lawless; Francesco Stellato; Sunil Saxena; Silvia Morante
Journal:  J Phys Chem B       Date:  2015-12-21       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.